Studies have shown that the positive rate of TRPS1 in ER-positive breast cancer is 98%, similar to GATA3 (96%), while the positive rate in triple-negative breast cancer (TNBC) is 86%, significantly higher than GATA3 (45%) [10]. This evidence concerns the gene GATA3 and triple-negative breast carcinoma.